Table 4.
Ages, comorbidity, and clinical outcomes of kidney transplant recipients with COVID-19 who continued to use immunosuppressants during hospitalization
| Patient age (year) | Comorbidity | No. of patients | No. with Positive Outcome | No. Remained Hospitalized | No. Death |
|---|---|---|---|---|---|
| ≤ 39 | No Comorbidity reported | 10 | 9 | 1 | 0 |
| HTN | 3 | 2 | 1 | 0 | |
| HTN + DM | 3 | 3 | 0 | 0 | |
| HTN + PKD | 1 | 0 | 1 | 0 | |
| HTN + Pericarditis | 1 | 1 | 0 | 0 | |
| Senior-Loken Syndrome | 1 | 1 | 0 | 0 | |
| TTMA | 1 | 1 | 0 | 0 | |
| 40-49 | No comorbidity Reported | 4 | 1 | 3 | 0 |
| HTN | 5 | 2 | 3 | 0 | |
| HTN + DM | 2 | 1 | 1 | 0 | |
| CGN | 1 | 1 | 0 | 0 | |
| 50-59 | No Comorbidity reported | 3 | 2 | 1 | 0 |
| HTN | 7 | 1 | 5 | 1 | |
| HTN + DM | 3 | 1 | 0 | 2 | |
| HCV | 1 | 0 | 0 | 1 | |
| HTN + HHD + COPD | 1 | 0 | 0 | 1 | |
| HTN + DM + CAD | 2 | 2 | 0 | 0 | |
| HTN + CAD | 1 | 1 | 0 | 0 | |
| HTN + DM + IHD | 1 | 0 | 1 | 0 | |
| HTN + HCV | 1 | 1 | 0 | 0 | |
| HTN + Hemolytic anemia | 1 | 1 | 0 | 0 | |
| CHD + AF + CHF | 1 | 1 | 0 | 0 | |
| PTDM + CMV | 1 | 0 | 1 | 0 | |
| RVT + CAD + Testicular cancer | 1 | 1 | 0 | 0 | |
| 60-69 | No comorbidity reported | 3 | 1 | 2 | 0 |
| HTN | 5 | 1 | 3 | 1 | |
| HTN + DM | 4 | 1 | 2 | 1 | |
| HTN + DM + CIN | 1 | 0 | 1 | 0 | |
| HTN + DM + IHD | 1 | 0 | 1 | 0 | |
| Breast Cancer | 1 | 0 | 1 | 0 | |
| CKD3A + MZL + PE + Parkinson + NB | 1 | 1 | 0 | 0 | |
| ≥70 | No Comorbidities Reported | 5 | 2 | 1 | 2 |
| HTN | 2 | 1 | 0 | 1 | |
| HTN + DM | 1 | 0 | 1 | 0 | |
| HTN + DM + CAD | 1 | 1 | 0 | 0 | |
| HTN + NRP + DM + PD | 1 | 1 | 0 | 0 | |
| HTN + IgA Nephropathy | 1 | 1 | 0 | 0 | |
| HTN + DM + NRP | 1 | 0 | 1 | 0 | |
| HTN + HD + COPD + Obesity | 1 | 0 | 0 | 1 | |
| HTN + Cancer | 1 | 0 | 0 | 1 | |
| HTN + PKD + PAC | 1 | 0 | 0 | 1 | |
| HTN + ESRD | 1 | 0 | 0 | 1 | |
| IHD | 1 | 0 | 0 | 1 |
Abbreviations. AF: atrial fibrillation; CAD: chronic allograft dysfunction; CKD3A: chronic kidney disease stage 3A; CGN: chronic glomerulus nephropathy; CHD: chronic heart disease; CHF: congestive heart failure; CMV: cytomegalovirus; COPD: chronic obstructive pulmonary disease; DM: diabetes; ESRD: end stage renal disease; HD: heart disease; HHD: Hypertensive heart disease; HTN: hyertension; IHD: ischemic heart disease; MZL: marginal zone lymphoma; NB: neurogenic bladder; NRP: nephropathy; PAC: prostate adenocarcinoma; PAD: peripheral artery disease; PE: pulmonary embolism; PKD: polycystic kidney disease; PTDM: post-transplantation diabetes mellitus; RVT: renal vein thrombosis; TTMA: transient thrombotic microangiopathy.